Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date | No Grouping
Number of items: 7.

Journal Article

Eysel-Gosepath, K., Pape, H. G., Erren, T., Thinschmidt, M., Lehmacher, W. and Piekarski, C. (2010). Sound levels in nursery schools. HNO, 58 (10). S. 1013 - 1021. NEW YORK: SPRINGER. ISSN 1433-0458

Hasford, J., Bramlage, P., Koch, G., Lehmacher, W., Einhaeupl, K. and Rothwell, P. M. (2010). Inconsistent trial assessments by the National Institute for Health and Clinical Excellence and IQWiG: standards for the performance and interpretation of subgroup analyses are needed. J. Clin. Epidemiol., 63 (12). S. 1298 - 1305. OXFORD: PERGAMON-ELSEVIER SCIENCE LTD. ISSN 0895-4356

Herich, L., Lehmacher, W. and Hellmich, M. (2015). Drop the Likelihood Ratio A Novel Non-electronic Tool for Interpreting Diagnostic Test Results. Methods Inf. Med., 54 (3). S. 283 - 288. STUTTGART: SCHATTAUER GMBH-VERLAG MEDIZIN NATURWISSENSCHAFTEN. ISSN 0026-1270

Hueser, C., Dieterich, P., Singh, J., Shah-Hosseini, K., Allekotte, S., Lehmacher, W., Compalati, E. and Moesges, R. (2017). A 12-week DBPC dose-finding study with sublingual monomeric allergoid tablets in house dust mite-allergic patients. Allergy, 72 (1). S. 77 - 85. HOBOKEN: WILEY. ISSN 1398-9995

Kuhr, K., Wirth, D., Srivastava, K., Lehmacher, W. and Hellmich, M. (2014). FIRST-LINE THERAPY FOR PATIENTS WITH MULTIPLE MYELOMA: DIRECT AND INDIRECT COMPARISON OF TREATMENT REGIMENS ON THE EXISTING MARKET. Value Health, 17 (7). S. A617 - 1. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1524-4733

Lehmacher, W., Klasser, M. and Duering, A. (2016). Letter to the editor: no increased febrile neutropenia risk to cancer patients receiving lipegfilgrastim-correction of a systematic review and meta-analysis of randomized controlled trials with G-CSF. Support. Care Cancer, 24 (5). S. 1935 - 1938. NEW YORK: SPRINGER. ISSN 1433-7339

Moesges, R., Demoly, P., Lehmacher, W., Durham, S., Shamji, M., Pirotton, S., Haazen, L. and Calderon, M. (2018). Safety of a 3-week allergen immunotherapy course with grass pollen peptides: A randomised double-blind placebo-controlled trial. Allergy, 73. S. 471 - 472. HOBOKEN: WILEY. ISSN 1398-9995

This list was generated on Mon May 23 03:28:52 2022 CEST.